CRBU Change in character

Updated
Watch fib line to retest level on up trend.
Bottom formed around $6.40
Note
Took profit @ $7.50. Possible rebuy after CPI report tomorrow
Note
Double top at 8.50. possible re test at 7.50-7.30 range. Buying back at those levels.
Note
Change of character formed at $7.75. Possible new bottom. 10 more days for short sellers to cover if price stays above $7 please double check me.
Note
Trendline starting to form from COC at $7.75 to 7.90. Confirmation of higher low "bottom" looks there.
Note
Looking for trendline to confirm at $8.20. If it holds, we then may test higher high.
Note
$6.50 per common share offering of 19.2 million shares. There are 61.36 mln shares outstanding thus having a 36% dilution. Pre market 7/14/2023 currently shows $7.70 or a negative 5.4% correction. This should retest $7.40 main trend line where it first formed at $5.80 (july 7th) then $6.40 (july 11), the next stop is $7.40. $7.4 would be a 9% correction. Price action most likely will be based on institutional interest on CRBU.
Note
Back in 6.50
Note
Next possible support @ $5.85
Note
Down trend look to be broken. Holding for now not buying any more nor selling.
Note
Pfizer 25 million share purchased at $5.44 + $6.50 share dilution price = $11.94 / 2 = an average price of $5.97. Decided to buy @ $6.10 this morning. If it goes lower, I will average down and go long.
Note
We are back at $6.50 support. We need to hold steady and create new base before continuing recovery.
Note
Hoping price action holds @ $6.75 to continue recovery.
Trade active
Convergence of Lower Highs and Higher Lows: Top trend line forming starting on 7/18/2023 @6.94 - 7/21/2023 @6.84 - today @6.80. Bottom trend line forming starting on 7/14/2023 @6.10 - 7/17/2023 @6.17- 7/23/2023 @6.35. If price action consolidates here in a tight range of an average price of 6.66. We should look for a breakout sometime on Thursday 2/27/2023. There should be a higher chance on the uptrend breakout considering past news and lagging indicators.
Note
FOMC DECISION ON INTEREST RATE HIKE 7/26/23 @ 2PM
Note
Good FOMC meeting. All in line comments. No color on stopping but possible another .25% more data coming in this week.
Note
HC Wainwright Adjusts Caribou Biosciences Price Target to $23 From $25, Maintains Buy Rating
Note
Nice run up today. Looking for a pull back and form a new higher low around $6.9 and $7. I think this maybe a new support line from here on and move higher, granted no negative news.
Note
Taking some profit at 7.50 buying back at 7
Note
Executed buy back. We may consolidate here in the range of 7 and 7.15 before next leg up.
Note
ADDED TODAY @ $6.75
EARNINGS ON THE 8TH
Note
ADDED TODAY @ $6.35. AVERAGING DOWN TO $6.20 AND HOLDING.
Note
LOOKING TO TAKE SOME PROFIT AT $7.8
Note
ADDED TODAY @ $6.15.
Note
ADDED TODAY @ 6.05 AND @ 5.97
Chart PatternsTechnical IndicatorsTrend Analysis

Disclaimer